Experience What's New at Esaote

Focus on ARAB HEALTH 2015

At Arab Health 2015 ESAOTE will showcase Virtual Navigator fusion imaging. ESAOTE recently received U.S. Food and Drug Administration (FDA) clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound to U.S. customers in addition to other worldwide countries. ESAOTE will showcase two new ultrasound machines, confirming its position as a leading innovator in the global ultrasound imaging market, delivering affordable productivity, efficiency and value. MyLabSix and MyLabGamma have been developed to address key sectors of the imaging market, reinforcing ESAOTE’s global ultrasound portfolio - from application-specific to fully shared services.

Download PDF
This page uses cookies. Visiting this web site, you approve the use of cookies. For more information about the use of cookies in this web site, please click on “More information”. I agree More information